Drugs / AD-211
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07550231 | Jun 2026 → Mar 2027 expected | osteoarthritis, knee | Addpharma Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AD-211 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07550231 ↗ |